CRISPR/Cas genome editing, functional genomics, and diagnostics for parasitic helminths
- PMID: 40348052
- PMCID: PMC12353640
- DOI: 10.1016/j.ijpara.2025.05.001
CRISPR/Cas genome editing, functional genomics, and diagnostics for parasitic helminths
Abstract
Functional genomics using CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats)/Cas (CRISPR-associated endonuclease)-based approaches has revolutionized biomedical sciences. Gene editing is also widespread in parasitology generally and its use is increasing in studies on helminths including flatworm and roundworm parasites. Here, we survey the progress, specifically with experimental CRISPR-facilitated functional genomics to investigate helminth biology and pathogenesis, and also with the burgeoning use of CRISPR-based methods to assist in diagnosis of helminth infections. We also provide an historical timeline of the introduction and uses of CRISPR in helminth species to date.
Keywords: CRISPR; Cas; Genome editing; Helminth parasites; Transgene.
Copyright © 2025 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Transferable approaches to CRISPR-Cas9 induced genome editing in non-model insects: a brief guide.Front Zool. 2025 Jul 7;22(1):13. doi: 10.1186/s12983-025-00566-2. Front Zool. 2025. PMID: 40624545 Free PMC article. Review.
-
CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities.World J Microbiol Biotechnol. 2025 Jun 25;41(7):223. doi: 10.1007/s11274-025-04458-9. World J Microbiol Biotechnol. 2025. PMID: 40560492 Review.
-
Versatile plant genome engineering using anti-CRISPR-Cas12a systems.Sci China Life Sci. 2024 Dec;67(12):2730-2745. doi: 10.1007/s11427-024-2704-7. Epub 2024 Aug 15. Sci China Life Sci. 2024. PMID: 39158766
-
Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis.Hum Gene Ther. 2025 Aug;36(15-16):1021-1052. doi: 10.1089/hum.2024.258. Epub 2025 Apr 28. Hum Gene Ther. 2025. PMID: 40295092 Review.
-
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.Hum Gene Ther. 2024 Oct;35(19-20):781-797. doi: 10.1089/hum.2024.020. Hum Gene Ther. 2024. PMID: 39276086 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources